Home › Companies › CHINOOK THERAPEUTICS INC. › 2023-2024

CHINOOK THERAPEUTICS INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and CHINOOK THERAPEUTICS INC.’s Form 8-K, filed August 3, 2023 (Item 5.07 on EDGAR). Page generated November 1, 2026.

  • 7Reported items
  • 204Asset managers
  • 826Fund votes
  • August 2, 2023Meeting date

Results at a glance

Meeting of August 2, 2023: 2 items on CHINOOK THERAPEUTICS INC.’s Form 8-K, filed August 3, 2023: 2 approved.

Material dissent

  • NEO Compensation Proposal 58% of votes cast Approved Under 80%

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024

Explore CHINOOK THERAPEUTICS INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by CHINOOK THERAPEUTICS INC.

These tallies are CHINOOK THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed August 3, 2023 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

CHINOOK THERAPEUTICS INC. — official shareholder meeting results, meeting held August 2, 2023
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Merger Agreement Proposal 55,926,8259,09978,817 ---- 99.9%Approved—
NEO Compensation Proposal 31,494,21722,485,5382,034,986 ---- 58%Approved—

Source: CHINOOK THERAPEUTICS INC., Form 8-K, filed with the SEC on August 3, 2023 — read the filing on EDGAR.

How asset managers voted at the CHINOOK THERAPEUTICS INC. 2023-2024 meeting

Each item below shows how the 204 asset managers that disclosed a CHINOOK THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of CHINOOK THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Merger Agreement Proposal

Official resultFund totals may overlapEXTRAORDINARY TRANSACTIONSReported outcome: Approved

Combines 8 wordings of this item as funds reported it.

99.9% Approved · of votes cast

FOR 99.9%
FOR: 55,926,825AGAINST: 9,099
Details: description as filed, official tally, votes by 70 asset managers

Description as filed by funds: To consider and vote upon the proposal to adopt the Agreement and Plan of Merger, dated as of June 11, 2023 (which, as it may be amended from time to time, we refer to as the "Merger Agreement"), by and among Chinook Therapeutics, Inc., a Delaware corporation (the "Company") Novartis AG, a company organized under the laws of Switzerland ("Novartis"), and Cherry Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Novartis ("Merger Sub"), pursuant to which Merger Sub will be merged with and into the Company (the "Merger"), with the Company to survive the Merger as an indirect wholly owned subsidiary of Novartis.

CHINOOK THERAPEUTICS INC.’s own tally for this item (“Merger Agreement Proposal”): 55,926,825 for, 9,099 against — passed, per its Form 8-K filed August 3, 2023 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Merger Agreement Proposal”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 68 asset managers voting on “To consider and vote upon the proposal to adopt the Agreement and Plan of Merger, dated as of June 11, 2023 (w” at CHINOOK THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,857,9950 00For
BlackRock2,409,1000 00For
MUTUAL FUND SERIES TRUST1,927,0000 00For
State Street1,797,9440 00For
Federated Hermes1,232,5460 00For
Dimensional1,113,6210 00For
Fidelity1,033,2200 00For
TIAA676,6450 00For
FRANKLIN STRATEGIC SERIES669,5460 00For
MERGER FUND454,3430 00For
Charles Schwab375,2390 00For
NEXPOINT FUNDS I276,1760 00For
Equitable122,4390 74,2200Mixed
Aberdeen150,8630 00For
Direxion Shares ETF Trust144,4820 00For
OLD WESTBURY FUNDS INC143,9350 00For
Northern Trust118,1650 00For
JPMorgan107,6480 00For
QUANTITATIVE MASTER SERIES LLC100,3640 00For
Lincoln Financial93,5610 00For
ProShares59,1000 00For
Jackson National54,5760 00For
ALPS ETF Trust49,1660 00For
Virtus47,9390 00For
Advisors' Inner Circle Fund III43,3660 00For

Fund voting reports, all 68 managers: 16,633,251 for, 74,220 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 2 asset managers voting on “To consider and vote upon the proposal to adopt the Agreement and Plan of Merger, dated as of June 11, 2023 (w” at CHINOOK THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Altium Capital Management LP305,0000 00For
UNITED CAPITAL FINANCIAL ADVISORS, LLC7,6000 00For

Institutional-manager reports, all 2 managers: 312,600 for.

2. To consider and vote upon the proposal to adjourn the Special Meeting, if necessary or appropriate, to solicit…

81% Fund and manager reports combined; may count the same shares twice · no official result

FORAGAINST
Details: description as filed, votes by 68 asset managers

Description as filed by funds: To consider and vote upon the proposal to adjourn the Special Meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to approve the proposal to adopt the Merger Agreement at the time of the Special Meeting.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 67 asset managers voting on “To consider and vote upon the proposal to adjourn the Special Meeting, if necessary or appropriate, to solicit” at CHINOOK THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard2,857,9950 00For
BlackRock2,409,1000 00For
State Street01,797,944 00Against
Federated Hermes1,232,5460 00For
Dimensional1,113,6210 00For
Fidelity24,3181,008,902 00Against
TIAA676,6450 00For
FRANKLIN STRATEGIC SERIES669,5460 00For
MERGER FUND454,3430 00For
Charles Schwab375,2390 00For
NEXPOINT FUNDS I276,1760 00For
Equitable122,4390 74,2200Mixed
Aberdeen150,8630 00For
Direxion Shares ETF Trust144,4820 00For
OLD WESTBURY FUNDS INC143,9350 00For
Northern Trust118,1650 00For
JPMorgan107,6480 00For
QUANTITATIVE MASTER SERIES LLC100,3640 00For
Lincoln Financial45,80147,760 00Mixed
ProShares59,1000 00For
Jackson National54,5760 00For
ALPS ETF Trust49,1660 00For
Virtus47,9390 00For
Advisors' Inner Circle Fund III43,3660 00For
Brinker Capital Destinations Trust38,4000 00For

Fund voting reports, all 67 managers: 11,842,537 for, 2,863,714 against, 74,220 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 1 asset manager voting on “To consider and vote upon the proposal to adjourn the Special Meeting, if necessary or appropriate, to solicit” at CHINOOK THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Altium Capital Management LP305,0000 00For

Institutional-manager reports, all 1 managers: 305,000 for.

3. To consider and vote upon the proposal to approve, on an advisory (non-binding) basis, certain compensation that may be…

No official matchSECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

0.3% of fund votes cast · no official result

AGAINST
Details: description as filed, votes by 124 asset managers

Description as filed by funds: To consider and vote upon the proposal to approve, on an advisory (non-binding) basis, certain compensation that may be paid or become payable to Chinook's named executive officers in connection with the Merger.

The 124 asset managers below reported 9,701,656 for, 4,495,219,018 against, 76,226 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 9,701,656AGAINST: 4,495,219,018ABSTAIN: 76,226
Largest asset managers voting on “To consider and vote upon the proposal to approve, on an advisory (non-binding) basis, certain compensation th” at CHINOOK THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
AQR Arbitrage LLC04,186,000,000 00Against
Janus Henderson0289,000,000 00Against
State Street4,611,931600 00For
BlackRock2,3404,009,948 00Against
Vanguard02,955,240 00Against
MUTUAL FUND SERIES TRUST1,927,0000 00For
SUVRETTA CAPITAL MANAGEMENT, LLC1,748,1410 00For
FRANKLIN ADVISERS INC01,268,649 00Against
Dimensional01,249,675 00Against
GEODE CAPITAL MANAGEMENT, LLC01,060,171 00Against
Fidelity01,036,479 00Against
Laurion Capital Management LP0768,670 00Against
Magnetar Financial LLC0732,629 00Against
AllianceBernstein0690,281 00Against
Nuveen0678,757 00Against
TIAA0676,645 00Against
FRANKLIN STRATEGIC SERIES0669,546 00Against
MERGER FUND454,3430 00For
Woodline Partners LP451,0260 00For
Hudson Bay Capital Management LP0417,012 00Against
Rock Springs Capital Management LP0396,280 00Against
MELLON INVESTMENTS Corp0295,153 00Against
Pentwater Capital Management LP0246,456 00Against
Vestal Point Capital, LP0239,261 00Against
DRIEHAUS CAPITAL MANAGEMENT LLC0211,616 00Against

Showing the 25 largest of 124 asset managers. See all 124 in the interactive database.

4. To consider and vote upon the proposal to approve, on an advisory (non-binding) basis, certain compensation that may be…

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 5 wordings of this item as funds reported it.

64% Fund and manager reports combined; may count the same shares twice · no official result

FORAGAINST
Details: description as filed, votes by 41 asset managers

Description as filed by funds: To consider and vote upon the proposal to approve, on an advisory (non-binding) basis, certain compensation that may be paid or become payable to the Company s named executive officers in connection with the Merger.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 9 asset managers voting on “To consider and vote upon the proposal to approve, on an advisory (non-binding) basis, certain compensation th” at CHINOOK THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Federated Hermes01,232,546 00Against
Charles Schwab0375,239 00Against
Advisors' Inner Circle Fund III043,366 00Against
SEI037,388 00Against
Equitable25,0000 00For
Gabelli19,0000 00For
Neuberger Berman6,6500 00For
Comstock Funds, Inc.1,5000 00For
GDL FUND1,0000 00For

Fund voting reports, all 9 managers: 53,150 for, 1,688,539 against.

Institutional-manager reports: 32 asset managers voting on “To consider and vote upon the proposal to approve, on an advisory (non-binding) basis, certain compensation th” at CHINOOK THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Samsara BioCapital, LLC5,161,8880 00For
FARALLON CAPITAL MANAGEMENT LLC1,444,9800 00For
Federated Hermes01,232,715 00Against
Man Group plc01,138,310 00Against
TIG Advisors, LLC856,3410 00For
Segantii Capital Management Ltd400,0000 00For
Charles Schwab0375,239 00Against
Altium Capital Management LP305,0000 00For
Saturn V Capital Management LP240,6550 00For
Nicholas Investment Partners, LP0206,206 00Against
KRYGER CAPITAL Ltd124,3540 00For
NEW YORK STATE COMMON RETIREMENT FUND055,483 00Against
HARVEST MANAGEMENT LLC48,4790 00For
BALYASNY ASSET MANAGEMENT L.P.043,038 00Against
SEI038,144 00Against
WASHINGTON STATE INVESTMENT BOARD036,867 00Against
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM021,769 00Against
Birchview Capital, LP15,0000 00For
Arizona State Retirement System012,946 00Against
Prudential/PGIM012,673 00Against
BANK OF AMERICA NA07,798 00Against
UNITED CAPITAL FINANCIAL ADVISORS, LLC07,600 00Against
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO04,747 00Against
MARSHALL WACE, LLP03,800 00Against
MACKENZIE FINANCIAL CORP03,765 00Against

Institutional-manager reports, all 32 managers: 8,598,335 for, 3,203,424 against, 2,000 not voted. Showing the 25 largest; see all in the interactive database.

5. To consider and vote upon the proposal to approve, on an advisory (non-binding) basis, certain compensation that may be…

No official matchFund totals may overlapSECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

71% Fund and manager reports combined; may count the same shares twice · no official result

FORAGAINSTABSTAIN
Details: description as filed, votes by 40 asset managers

Description as filed by funds: To consider and vote upon the proposal to approve, on an advisory (non-binding) basis, certain compensation that may be paid or become payable to Company's named executive officers in connection with the Merger

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports: 11 asset managers voting on “To consider and vote upon the proposal to approve, on an advisory (non-binding) basis, certain compensation th” at CHINOOK THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
NEXPOINT FUNDS I0276,176 00Against
JPMorgan0107,648 00Against
Jackson National38,93315,643 00Mixed
AltShares Trust30,1020 00For
Exchange Place Advisors Trust029,400 00Against
John Hancock022,357 00Against
Bridge Builder Trust019,522 00Against
Lincoln Financial011,032 00Against
Allianz06,176 00Against
NORTHERN LIGHTS FUND TRUST II2,0930 00For
WILSHIRE MUTUAL FUNDS INC0249 00Against

Fund voting reports, all 11 managers: 71,128 for, 488,203 against.

Institutional-manager reports: 29 asset managers voting on “To consider and vote upon the proposal to approve, on an advisory (non-binding) basis, certain compensation th” at CHINOOK THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
BAKER BROS. ADVISORS LP00 1,455,2020Abstain
MPM BioImpact LLC1,003,4060 00For
Ensign Peak Advisors, Inc359,4800 00For
Affinity Asset Advisors, LLC321,0150 00For
Sand Grove Capital Management LLP249,4620 00For
BAILLIE GIFFORD & CO LTD0183,933 00Against
Gabelli164,7500 00For
JPMorgan063,983 00Against
Northern Trust057,908 00Against
Centiva Capital, LP050,938 00Against
Westchester Capital Management, LLC47,1220 00For
BAILLIE GIFFORD OVERSEAS LTD040,849 00Against
WATER ISLAND CAPITAL LLC30,1020 00For
Baillie Gifford Investment Management (Europe) Ltd016,974 00Against
Polar Asset Management Partners Inc.15,0000 00For
PenderFund Capital Management Ltd.10,2400 00For
PNC BANK, NATIONAL ASSOCIATION06,400 00Against
WESTCHESTER CAPITAL PARTNERS, LLC4,2210 00For
COBBLESTONE CAPITAL ADVISORS LLC /NY/04,000 00Against
XPONANCE, INC.02,930 00Against
Natixis0917 00Against
Chicago Partners Investment Group LLC7130 00For
OPPENHEIMER & CO INC0350 00Against
Greenfield Savings Bank3100 00For
Corient Private Wealth LLC0139 00Against

Institutional-manager reports, all 29 managers: 2,206,063 for, 429,321 against, 1,455,202 abstained. Showing the 25 largest; see all in the interactive database.

6. Advisory Vote on Golden Parachutes

No official matchSECTION 14A SAY-ON-PAY VOTES

40% of fund votes cast · no official result

FORAGAINST
Details: votes by 5 asset managers

The 5 asset managers below reported 134,110 for, 205,401 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 134,110AGAINST: 205,401
Largest asset managers voting on “Advisory Vote on Golden Parachutes” at CHINOOK THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
JPMorgan0185,660 00Against
ADAGE CAPITAL PARTNERS GP, L.L.C.134,1100 00For
ALGERT GLOBAL LLC018,850 00Against
Desjardins Global Asset Management Inc.0881 00Against
TD ASSET MANAGEMENT INC010 00Against

7. Merger Agreement Proposal

Official resultSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

99.9% Approved · of votes cast

FOR 99.9%
FOR: 55,926,825AGAINST: 9,099
Details: description as filed, official tally, votes by 2 asset managers

Description as filed by funds: To consider and vote upon the proposal to approve on an advisory (non-binding) basis, certain compensations that may be paid or become payable to the Company's named executive officers in connection with the Merger

CHINOOK THERAPEUTICS INC.’s own tally for this item (“Merger Agreement Proposal”): 55,926,825 for, 9,099 against — passed, per its Form 8-K filed August 3, 2023 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Merger Agreement Proposal”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 2 asset managers below reported 698 against.

AGAINST
AGAINST: 698
Largest asset managers voting on “To consider and vote upon the proposal to approve on an advisory (non-binding) basis, certain compensations th” at CHINOOK THERAPEUTICS INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Orion Porfolio Solutions, LLC0349 00Against
Orion Portfolio Solutions, LLC0349 00Against

Largest CHINOOK THERAPEUTICS INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported.

Fund voting reports: top CHINOOK THERAPEUTICS INC. shareholders by shares voted on “To consider and vote upon the proposal to adopt the Agreement and Plan of Merger, dated as of…”, 2023-2024
#Asset manager Shares voted
1Vanguard 2,857,995
2BlackRock 2,409,100
3MUTUAL FUND SERIES TRUST 1,927,000
4State Street 1,797,944
5Federated Hermes 1,232,546
6Dimensional 1,113,621
7Fidelity 1,033,220
8TIAA 676,645
9FRANKLIN STRATEGIC SERIES 669,546
10MERGER FUND 454,343
Institutional-manager reports: top CHINOOK THERAPEUTICS INC. shareholders by shares voted on “To consider and vote upon the proposal to approve, on an advisory (non-binding) basis, certain…”, 2023-2024
#Asset manager Shares voted
1AQR Arbitrage LLC 4,186,000,000
2Janus Henderson 289,000,000
3State Street 2,814,587
4SUVRETTA CAPITAL MANAGEMENT, LLC 1,748,141
5BlackRock 1,603,188
6FRANKLIN ADVISERS INC 1,268,649
7GEODE CAPITAL MANAGEMENT, LLC 1,060,171
8Laurion Capital Management LP 768,670
9Magnetar Financial LLC 732,629
10Nuveen 678,757

Shown as share counts, not percentages: no shares-outstanding figure has been matched to CHINOOK THERAPEUTICS INC. for the 2023-2024 season, so there is no denominator to divide by.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. This page is a static snapshot rebuilt weekly on November 1, 2026; a live search always shows the current data.

At CHINOOK THERAPEUTICS INC.'s shareholder meeting held August 2, 2023, in the 2023-2024 proxy season, 204 asset managers reported how they voted in their SEC Form N-PX filings, covering 826 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. CHINOOK THERAPEUTICS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To consider and vote upon the proposal to approve, on an advisory (non-binding) basis, certain… — the reporting funds cast 0.3% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

CHINOOK THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page).

Download data (CSV): ballot items · votes by manager · column guide.